SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001610618-24-000041
Filing Date
2024-04-22
Accepted
2024-04-22 16:56:44
Documents
110
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. 2023 FORM 10-K cdtx-20231231.htm   iXBRL 10-K 3698511
2 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION exhibit322023-12.htm EX-3.2 10689
3 AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY exhibit1052023-12.htm EX-10.5 16408
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312023-12.htm EX-23.1 3225
5 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112023-12.htm EX-31.1 11487
6 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122023-12.htm EX-31.2 11737
7 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212023-12.htm EX-32.1 7006
8 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222023-12.htm EX-32.2 7297
9 INCENTIVE COMPENSATION RECOUPMENT POLICY exhibit9712023-12.htm EX-97.1 45272
15 GRAPHIC cdtx-20231231_g1.jpg GRAPHIC 23028
16 GRAPHIC cdtx-20231231_g10.jpg GRAPHIC 131758
17 GRAPHIC cdtx-20231231_g11.jpg GRAPHIC 110340
18 GRAPHIC cdtx-20231231_g12.jpg GRAPHIC 47123
19 GRAPHIC cdtx-20231231_g13.jpg GRAPHIC 581005
20 GRAPHIC cdtx-20231231_g14.jpg GRAPHIC 634367
21 GRAPHIC cdtx-20231231_g15.jpg GRAPHIC 637536
22 GRAPHIC cdtx-20231231_g2.jpg GRAPHIC 265744
23 GRAPHIC cdtx-20231231_g3.jpg GRAPHIC 40726
24 GRAPHIC cdtx-20231231_g4.jpg GRAPHIC 33311
25 GRAPHIC cdtx-20231231_g5.jpg GRAPHIC 78600
26 GRAPHIC cdtx-20231231_g6.jpg GRAPHIC 60994
27 GRAPHIC cdtx-20231231_g7.jpg GRAPHIC 49980
28 GRAPHIC cdtx-20231231_g8.jpg GRAPHIC 80495
29 GRAPHIC cdtx-20231231_g9.jpg GRAPHIC 42486
  Complete submission text file 0001610618-24-000041.txt   22617574

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20231231.xsd EX-101.SCH 61099
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20231231_cal.xml EX-101.CAL 87767
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20231231_def.xml EX-101.DEF 422786
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20231231_lab.xml EX-101.LAB 669112
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20231231_pre.xml EX-101.PRE 620727
114 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20231231_htm.xml XML 3526707
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36912 | Film No.: 24861831
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)